Merck short on moral values
19416
As Democrats continue to search heaven and Earth for a moral values issue they can call their own, I have just the prescription: Why not start with the immoral behavior of giant drug companies such as Merck that continue to sacrifice the health of the
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
298813
Merck &amp; Co.'s decision to pull its widely prescribed drug Vioxx off the shelves yesterday because of a risk of stroke and heart attacks marked a new low for a pharmaceutical company that has suffered a steady decline in both market position and prestige over the last decade.
175709
Investors care more about the drugmaker's future than its Q4 results.
667
The Food and Drug Administration insists that until pharmaceutical giant Merck presented new information this week, there was not enough evidence to pull the arthritis drug Vioxx off the market.
155751
NEW YORK/WHITEHOUSE STATION, New Jersey  - Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and it aims to have another four products in late-stage trials by mid-year, the company said on Tuesday.
201667
WALL STREET analysts last night said a second experimental pain killer under development by Merck, the American drugs maker, could be delayed until 2007, after regulators asked for more information on the medicineâs safety.
80437
A New Jersey jury ruled that Merck failed to provide adequate warning about the risks of its Vioxx painkiller in one of two cases decided.
615822
When Merck&#39;s arthritis drug Vioxx was withdrawn from the market in September, concerns over drug safety were pretty much under the radar for the most part, but not today.
416045
Merck & Co Inc. is evaluating why  its withdrawn painkiller Vioxx raises the chance of heart  attack and stroke, but it has not found a mechanism of action,  a company official said on Monday.
294702
The reputation of the drug industry took another heavy blow yesterday with a report suggesting that Merck had fought for years to cover up evidence linking its painkiller Vioxx to heart attacks and strokes.
597705
SILVER SPRING, Maryland  - A U.S. advisory panel urged the government on Thursday to reject Merck & Co Inc's latest bid to sell a cholesterol-lowering drug without a prescription.
557443
Top executives at pharmaceutical giant Merck & Co. Inc. decided in May 2000 against developing a study to test directly whether its Vioxx painkiller drug might pose a heart risk, The New York Times reported on Saturday.
722689
BETHESDA, Md.  - Drug maker Merck & Co. Inc.   urged U.S. advisers on Thursday to approve the first  over-the-counter sales of a cholesterol-lowering pill, but  regulators questioned if consumers would use it properly.
446961
This article was reported and written by Alex Berenson, Gardiner Harris, Barry Meier and Andrew Pollack. In May 2000, executives at Merck, the pharmaceutical giant under siege for its
596071
ATLANTIC CITY, New Jersey  - A New Jersey jury found on Friday that Merck & Co.  failed to provide adequate warnings about health risks tied to its withdrawn arthritis drug Vioxx in one case, but decided that it gave adequate warning in another in two suits tried simultaneously.
428395
Merck & Co Inc. is evaluating why its withdrawn painkiller Vioxx raises the chance of heart attack and stroke, but it has not found a mechanism of action, a company official said on Monday.